• Home
  • Company
    • Overview
    • Board of Directors
    • Management Team
    • Corporate Governance
    • Contact Us
  • Product Candidates
    • Product Candidates Overview
    • Cardiovascular Diseases
    • Spine Orthopedic Disorders
    • Oncology & Hematology
    • Immune-Mediated & Inflammatory Conditions
    • Clinical Trials
    • Expanded Access Policy
  • Science
    • Mesenchymal Lineage Cells
    • Mechanisms of Action
    • Manufacturing
    • Intellectual Property
    • Scientific Publications
  • Partnerships
    • Overview
  • Investors & Media
    • At A Glance
    • Company Announcements
    • Share Price & Tools
    • Events & Presentations
    • Financial Information
    • Shareholder Services
  • Careers
    • Current Opportunities
Mesoblast
Home Contact Us
  • Home
  • Company
    • Overview
    • Board of Directors
    • Management Team
    • Corporate Governance
    • Contact Us
  • Product Candidates
    • Product Candidates Overview
    • Cardiovascular Diseases
    • Spine Orthopedic Disorders
    • Oncology & Hematology
    • Immune-Mediated & Inflammatory Conditions
    • Clinical Trials
    • Expanded Access Policy
  • Science
    • Mesenchymal Lineage Cells
    • Mechanisms of Action
    • Manufacturing
    • Intellectual Property
    • Scientific Publications
  • Partnerships
    • Overview
  • Investors & Media
    • At A Glance
    • Company Announcements
    • Share Price & Tools
    • Events & Presentations
    • Financial Information
    • Shareholder Services
  • Careers
    • Current Opportunities

Stem Cell Technology

  • Enrichment for STRO - 1 Expression Enhances the Cardiovascular Paracrine Activity of Human Bone Marrow - Derived Mesenchymal Cell Populations - Journal of Cell Physiology, May 2010
  • Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow - Journal of Cell Science, 14 January 2003
  • Perivascular Niche of Postnatal Mesenchymal Stem Cells in Human Bone Marrow and Dental Pulp - Journal of Bone and Mineral Research, 2003
  • Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression - Nature Biotechnology, June 2002
  • Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo - Proceedings of the National Academy of Sciences (PNAS), 5 December 2000
  • Differential Cell Surface Expression of the STRO-1 and Alkaline Phosphatase Antigens on Discrete Developmental Stages in Primary Cultures of Human Bone Cells - Journal of Bone and Mineral Research, 1999
  • The Growth Factor Requirements of STRO-1 -Positive Human Bone Marrow Stromal Precursors under Serum-Deprived Conditions In Vitro - Blood, 15 February 1995
  • The STRO-1 + Fraction of Adult Bone Marrow contains the Osteogenic Precursors - Blood, 15 December 1994
  • Mesenchymal Lineage Cells
    • Complementary Technologies
  • Mechanisms of Action
  • Manufacturing
  • Intellectual Property
  • Scientific Publications
    • Stem Cell Technology
    • Cardiac and Vascular
    • Orthopedic
    • Immune and Inflammatory
    • Oncology
    • Neurologic
  • Home
  • Company
    • Overview
    • Board of Directors
    • Management Team
    • Corporate Governance
    • Contact Us
  • Product Candidates
    • Product Candidates Overview
    • Cardiovascular Diseases
    • Spine Orthopedic Disorders
    • Oncology & Hematology
    • Immune-Mediated & Inflammatory Conditions
    • Clinical Trials
    • Expanded Access Policy
  • Science
    • Mesenchymal Lineage Cells
    • Mechanisms of Action
    • Manufacturing
    • Intellectual Property
    • Scientific Publications
  • Partnerships
    • Overview
  • Investors & Media
    • At A Glance
    • Company Announcements
    • Share Price & Tools
    • Events & Presentations
    • Financial Information
    • Shareholder Services
  • Careers
    • Current Opportunities
  • Copyright © 2025 Mesoblast Ltd
  • Disclaimer
  • Privacy Policy
  • Search